Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.

• If you are wondering whether Praxis Precision Medicines is still priced attractively after its big run, this article will walk through what that current share price could imply about the company.

• The stock recently closed at US$293.95, with a 1 year return that is very large and a 2.6% gain year to date, even though the last 7 days and 30 days have seen returns of 5.4% and 7.3% declines.

• Recent market attention around Praxis, including coverage of its progress as a clinical stage neuroscience company and updates on its development pipeline, has helped frame…